Anti-tumor necrosis factor α F(ab')2 antibody fragments protect in murine polymicrobial sepsis: Concentration and early intervention are fundamental to the outcome (original) (raw)

The role of tumor necrosis factor in sepsis

Louis Saravolatz

Clinical immunology and immunopathology, 1992

View PDFchevron_right

Dosage and Timing of Anti-TNF-α Antibody Treatment Determine Its Effect on Resistance to Sepsis after Injury

Richard Molloy

Journal of Surgical Research, 1996

View PDFchevron_right

LYMPHOTOXIN-α (TNF-β) DURING SEPSIS

david moyes

Cytokine, 1996

View PDFchevron_right

SERUM PROFILE OF IL6, TNFALPHA, IL12 AND IFNGAMMA IN EARLY SEPSIS

Adriana Slavcovici

View PDFchevron_right

Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity

Didier Ledoux

Annals of Surgery, 1992

View PDFchevron_right

Acute Lung Injury and Acute Kidney Injury Are Established by Four Hours in Experimental Sepsis and Are Improved with Pre, but Not Post, Sepsis Administration of TNF-α Antibodies

A. Andres-hernando, Christopher Altmann

PLoS ONE, 2013

View PDFchevron_right

Anti-TNF Treatment of Baboons with Sepsis Reduces TNF-α, IL-6 and IL-8, but not the Degree of Complement Activation

Heinz Redl

Scandinavian Journal of Immunology, 1998

View PDFchevron_right

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

Steven Berman, Richard Wunderink

Journal of Cardiothoracic and Vascular Anesthesia, 1998

View PDFchevron_right

Pathophysiological role of pro-and anti-inflammatory cytokines in sepsis

Jean Marc Cavaillon

Sepsis, 1998

View PDFchevron_right

Is TNF-α a prognostic factor in patients with sepsis?

Pramod Shah

Clinical Microbiology and Infection, 1997

View PDFchevron_right

Immunopathologic alterations in murine models of sepsis of increasing severity

Samuel Ebong

Infection and immunity, 1999

View PDFchevron_right

Inhibition of Macrophage-activating Cytokines is Beneficial in the Acute Septic Response

Henry Redmond

Annals of Surgery, 1991

View PDFchevron_right

Vascular Endothelial Growth Factor Blockade Reduces Plasma Cytokines in a Murine Model of Polymicrobial Sepsis

Anna Nolan

Inflammation, 2004

View PDFchevron_right

Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis

Richard Knight, Catherine Betts

Inflammation Research, 2014

View PDFchevron_right

Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-αreceptor (TNF-RI)? A study in TNF-RI (TNF-RI–/–) knock-out rodents

Christian Krettek

Clinical and Experimental Immunology, 2004

View PDFchevron_right

Immunopathologic responses to non-lethal sepsis

Samuel Ebong

1999

View PDFchevron_right

Immunoinflammatory Response in Critically Ill Patients: Severe Sepsis and/or Trauma

Jasna Jevdjic, Milic Veljovic

Mediators of Inflammation, 2013

View PDFchevron_right

Is TNF-a a prognostic factor in patients with sepsis?

Pramod Shah

Clin Microbiol Infect, 1997

View PDFchevron_right

Proinflammatory versus anti-inflammatory response in sepsis patients: looking at the cytokines

Sumit Ray

Critical Care, 2014

View PDFchevron_right

Immunomodulation in Polytrauma and Polymicrobial Sepsis - Where Do We Stand?

Claudia Neunaber

Recent Patents on Inflammation & Allergy Drug Discovery, 2011

View PDFchevron_right

Double-blind randomised controlled-trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock (NORASEPT II Study Group)

Guillermo Gutierrez

Lancet, 1998

View PDFchevron_right

Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review

Jean Marc Cavaillon

Journal of endotoxin research, 2001

View PDFchevron_right

Divergence of protection induced by bacterial products and sepsis-induced immune suppression. Infect. Immun

Theo Sterns

2005

View PDFchevron_right

Involvement of Pro- and Anti-Inflammatory Cytokines in Sepsis

Jenna Ziebell

The Sepsis Text, 2002

View PDFchevron_right

Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic Shock

Alan Cross

Journal of Infectious Diseases, 1996

View PDFchevron_right

Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression

Theo Sterns

View PDFchevron_right